Article Text

Download PDFPDF
Management of refractory immune thrombocytopaenia in pregnancy
  1. Jessica M Heenan
  1. Haematology, Launceston General Hospital, Launceston, Tasmania, Australia
  1. Correspondence to Dr Jessica M Heenan; jessica.heenan{at}ths.tas.gov.au

Abstract

A 25-year-old woman with a history of immune thrombocytopaenia (ITP) in childhood was referred to haematology clinic for review with a platelet count of 50 μ/L at 9 weeks gestation, gravida 2, para 0. She developed progressive severe thrombocytopaenia as the pregnancy progressed, with associated bleeding complications. The thrombocytopaenia was refractory to standard therapies. This led to a need for a planned delivery, which was performed via caesarean section under general anaesthetic with platelet transfusion support, Intravenous Immune Globulin (IVIG), high-dose corticosteroid and the thrombopoietin (TPO) mimetic romiplostim. Both the mother and the neonate survived; however, the neonate required treatment for severe prolonged neonatal thrombocytopaenia. The patient subsequently re-presented 15 months later with recurrent ITP complicating another pregnancy, refractory to rituximab but responsive to romiplostim. She had a successful elective caesarean section under epidural anaesthesia, but the neonate once again suffered severe thrombocytopaenia, which was responsive to IVIG.

  • haematology (drugs and medicines)
  • obstetrics
  • gynaecology and fertility
  • haematology (incl blood transfusion)
  • materno-foetal medicine
  • neonatal health

Statistics from Altmetric.com

Footnotes

  • Contributors JMH: sole author and contributed 100% to the concept, planning, design, data accrual, writing and submission of the manuscript.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.